Reduced Risk of Atrial Fibrillation Following Cholecystectomy: A Nationwide Population-Based Study

Tung Ching Ho1,2, Yu-Ching Chen2, Che-Chen Lin3

  • 1Department of Cardiology, Chang Hua Hospital, Changhua County, Taiwan.

Insights

Gallstone disease (GD) significantly increases the risk of developing atrial fibrillation (AF). Cholecystectomy, a gallbladder removal surgery, was associated with a reduced risk of AF in patients with GD.

Area of Science:

  • Cardiology
  • Gastroenterology
  • Epidemiology

Background:

  • Gallstone disease (GD) is a known risk factor for cardiovascular disease.
  • The association between GD and atrial fibrillation (AF) has not been previously established.
  • Investigating this link is crucial for understanding cardiovascular risks associated with GD.

Purpose of the Study:

  • To determine if gallstone disease (GD) is associated with an increased risk of atrial fibrillation (AF).
  • To evaluate the impact of cholecystectomy on AF risk in patients with GD.
  • To analyze AF risk in relation to age and CHA2DS2-VASc scores within the GD population.

Main Methods:

  • A population-based cohort study utilizing the Taiwan National Health Insurance Research Database (2001-2011).
  • A cohort of 230,076 patients with GD was compared to an equal number of matched controls.
  • Statistical analysis included hazard ratios (HR) and 95% confidence intervals (CI) to assess AF risk.

Main Results:

  • Patients with GD had a significantly higher risk of developing AF (HR: 1.20, 95% CI: 1.16-1.25).
  • GD patients without cholecystectomy showed a markedly increased AF risk (HR: 1.57, 95% CI: 1.50-1.63).
  • Cholecystectomy was associated with a reduced AF risk (HR: 0.85, 95% CI: 0.81-0.90).
  • AF risk increased with age and CHA2DS2-VASc score in the GD cohort.

Conclusions:

  • Gallstone disease is independently associated with an elevated risk of atrial fibrillation.
  • Cholecystectomy may mitigate the risk of AF in patients with gallstone disease.
  • Regular cardiovascular monitoring is recommended for GD patients, particularly younger individuals with additional risk factors.